| | | | Announces Q4 & FY12 Results & Auditors Report for March 31, 2012 | 05/12/12 10:10 | | | | AstraZeneca Pharma India Ltd has announced the following results for the quarter & year ended March 31, 2012
The Unaudited results for the Quarter ended March 31, 2012
The Company has posted a net loss of Rs. (330.045) million for the quarter ended March 31, 2012 where as the same was at net profit of Rs. 83.539 million for the quarter ended March 31, 2011. Total Income is Rs. 938.009 million for the quarter ended March 31, 2012 where as the same was at Rs. 1288.747 million for the quarter ended March 31, 2011.
The Audited results for the Year ended March 31, 2012
The Company has posted a net profit of Rs. 197.651 million for the year ended March 31, 2012 where as the same was at Rs. 641.296 million for the 15months year ended March 31, 2011. Total Income is Rs. 5378.506 million for the year ended March 31, 2012 where as the same was at Rs. 6003.064 million for the 15months year ended March 31, 2011.
- The Board of Directors at their meeting held on February 23, 2010 have approved the change in the Company's statutory accounting year from "January-December" to "April- March". The financial accounts and annual report for the year ending March 31, 2011 was for a period of 15 months, i.e. from January 01, 2010 to March 31, 2011. Accordingly, the year to date figures for the current year ended March 31, 2012 are for a 12 months period, while the corresponding figures are for a 15 months period and hence not strictly comparable. | |
|